Market Closed -
Abu Dhabi Securities Exchange
03:14:02 2024-04-16 am EDT
|
5-day change
|
1st Jan Change
|
1.8
AED
|
0.00%
|
|
0.00%
|
-6.25%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
1,223
|
1,083
|
1,677
|
1,188
|
1,510
|
1,342
|
Enterprise Value (EV)
1 |
1,112
|
1,002
|
1,588
|
1,056
|
1,371
|
1,188
|
P/E ratio
|
10.8
x
|
16.7
x
|
48.5
x
|
33.4
x
|
41.2
x
|
22.4
x
|
Yield
|
5.71%
|
6.45%
|
4.17%
|
5.88%
|
4.63%
|
5.21%
|
Capitalization / Revenue
|
2.52
x
|
2.03
x
|
3.44
x
|
2.44
x
|
3
x
|
2.36
x
|
EV / Revenue
|
2.29
x
|
1.87
x
|
3.26
x
|
2.17
x
|
2.72
x
|
2.09
x
|
EV / EBITDA
|
35.4
x
|
15
x
|
26.6
x
|
19.5
x
|
29.6
x
|
16.6
x
|
EV / FCF
|
-15.6
x
|
93.5
x
|
51.7
x
|
10.6
x
|
28.9
x
|
24.9
x
|
FCF Yield
|
-6.4%
|
1.07%
|
1.93%
|
9.43%
|
3.46%
|
4.02%
|
Price to Book
|
1.08
x
|
0.97
x
|
1.56
x
|
1.09
x
|
1.41
x
|
1.21
x
|
Nbr of stocks (in thousands)
|
698,916
|
698,916
|
698,916
|
698,916
|
698,916
|
698,916
|
Reference price
2 |
1.750
|
1.550
|
2.400
|
1.700
|
2.160
|
1.920
|
Announcement Date
|
2/21/19
|
2/23/20
|
2/7/21
|
2/10/22
|
2/2/23
|
2/13/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
485.5
|
534.9
|
487.3
|
486.8
|
503.8
|
569.6
|
EBITDA
1 |
31.37
|
66.94
|
59.81
|
54.04
|
46.33
|
71.55
|
EBIT
1 |
-2.8
|
32.9
|
32.62
|
29.36
|
22.05
|
47.07
|
Operating Margin
|
-0.58%
|
6.15%
|
6.69%
|
6.03%
|
4.38%
|
8.26%
|
Earnings before Tax (EBT)
1 |
119.7
|
75.2
|
41.37
|
44.01
|
43.52
|
75.23
|
Net income
1 |
113.2
|
64.95
|
34.55
|
35.58
|
36.6
|
59.81
|
Net margin
|
23.32%
|
12.14%
|
7.09%
|
7.31%
|
7.26%
|
10.5%
|
EPS
2 |
0.1620
|
0.0929
|
0.0494
|
0.0509
|
0.0524
|
0.0856
|
Free Cash Flow
1 |
-71.2
|
10.72
|
30.72
|
99.56
|
47.43
|
47.77
|
FCF margin
|
-14.66%
|
2%
|
6.3%
|
20.45%
|
9.41%
|
8.39%
|
FCF Conversion (EBITDA)
|
-
|
16.01%
|
51.37%
|
184.22%
|
102.37%
|
66.77%
|
FCF Conversion (Net income)
|
-
|
16.51%
|
88.91%
|
279.81%
|
129.58%
|
79.88%
|
Dividend per Share
2 |
0.1000
|
0.1000
|
0.1000
|
0.1000
|
0.1000
|
0.1000
|
Announcement Date
|
2/21/19
|
2/23/20
|
2/7/21
|
2/10/22
|
2/2/23
|
2/13/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
111
|
81.2
|
88.9
|
132
|
139
|
154
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-71.2
|
10.7
|
30.7
|
99.6
|
47.4
|
47.8
|
ROE (net income / shareholders' equity)
|
9.62%
|
6.52%
|
3.66%
|
3.92%
|
3.85%
|
6.54%
|
ROA (Net income/ Total Assets)
|
-0.1%
|
1.44%
|
1.51%
|
1.41%
|
1.06%
|
2.22%
|
Assets
1 |
-108,995
|
4,511
|
2,284
|
2,531
|
3,451
|
2,699
|
Book Value Per Share
2 |
1.620
|
1.600
|
1.530
|
1.560
|
1.530
|
1.580
|
Cash Flow per Share
2 |
0.3500
|
0.2400
|
0.2100
|
0.1700
|
0.1600
|
0.1800
|
Capex
1 |
66.3
|
31.9
|
7.75
|
7.91
|
12.3
|
15.4
|
Capex / Sales
|
13.66%
|
5.97%
|
1.59%
|
1.62%
|
2.44%
|
2.71%
|
Announcement Date
|
2/21/19
|
2/23/20
|
2/7/21
|
2/10/22
|
2/2/23
|
2/13/24
|
|
1st Jan change
|
Capi.
|
---|
| -6.25% | 342M | | -14.92% | 84.68B | | +13.30% | 81.12B | | +11.62% | 29.4B | | -12.71% | 16.73B | | -3.06% | 16.36B | | -2.63% | 14.92B | | -31.75% | 11.77B | | -1.42% | 11.72B | | +27.44% | 11.71B |
Other Healthcare Facilities & Services
|